Verve Therapeutics Inc. (VERV)
NASDAQ: VERV
· Real-Time Price · USD
11.13
0.03 (0.27%)
At close: Jul 24, 2025, 3:59 PM
Verve Therapeutics Revenue
Verve Therapeutics reported an annual revenue of $32.33M, reflecting a 174.98% growth. For the quarter ending March 31, 2025, Verve Therapeutics generated $32.98M in revenue.
Revenue (ttm)
32.33M
Revenue Growth
174.98%
Price / Sales Ratio
14.78
Revenue / Employee
118K
Employees
274
Market Cap
994.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 32.33M | +174.98% |
| Dec 31, 2023 | 11.76M | +505.77% |
| Dec 31, 2022 | 1.94M | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |